IP Verse

Takeda Pharmaceutical Company Limited competitive analysis

Latest oppositions filed by Takeda Pharmaceutical Company Limited

Explore patent oppositions filed by Takeda Pharmaceutical Company Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3377103
Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted CellsREVITOPE LIMITEDDec 17, 2021

Latest patents of Takeda Pharmaceutical Company Limited opposed by its competitors

Explore Takeda Pharmaceutical Company Limited's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3518933
Feb 26, 2025Methods Of Treating Uterine Fibroids And Endometriosis1
EP2300013
Nov 13, 2024Phosphorous Derivatives As Kinase Inhibitors1
EP3518932
Nov 13, 2024Treatment Of Prostate Cancer2
EP3782986
Jul 10, 2024Heterocyclic Compound1
EP4233847
Jul 10, 2024A Tablet Comprising A Methoxyurea Derivative And Mannitol Particles1
EP3237004
May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody1
EP3370729
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma1
EP3263110
May 10, 2023Solid Preparation1
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same1
EP3626258
Aug 4, 2021Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase1

Latest PTAB cases involving Takeda Pharmaceutical Company Limited

Discover the latest PTAB cases involving Takeda Pharmaceutical Company Limited, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 27, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Takeda Pharmaceutical Company Limited

IPR2015-00754Feb 17, 2015ARRAY BIOPHARMATAKEDA PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Takeda Pharmaceutical Company Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TAKEDA PHARMACEUTICAL126 - 1
GREEN CROSS CORPORATION2 - 1 -
INSTONE, TERRY/READ, HOWARD GRAHAM/APPLEYARD LEES IP LLP9 - - -
SANDOZ1321919 -